You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

80 Results
Statistical Reports
Apr 2018
Statistical Reports
Apr 2018
Statistical Reports
Jan 2018
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    dexamethasone
ODB - General Benefit
    cyclophosphamide - oral tablets
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
carfilzomib (Unfunded),
cyclophosphamide,
dexamethasone
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2023
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
amivantamab (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2023
Guidelines and Advice
Status: Current
ID: 5-2
Version: 2
Oct 2023
Guidelines and Advice
Status: In-Review
ID: 4-17
Version: 2
Jan 2018
Drug
Quick Link(s): Drug Monograph, Patient Info Sheet
Oct 2023

Pages